CASPR PROGRAM NEWS
NIH High Leverage Trials (HILT) Proposal
A new policy brief proposing an NIH High-Leverage Trials program for large-scale drug repurposing and supplement research.
CASPR GLP-1 event with Congressional Addiction Caucus on Jan 13
If you are in DC, we'd love to have you join us.
Washington Post covers both of CASPR's GLP-1 pilot programs
Coverage of our programs at Caron and OpenDoors reaches DC policymakers.
New York Times covers our pilot program with Open Doors
GLP-1s for women in post-incarceration housing.
FDA's new National Priority Vouchers could grow the addiction medicine pipeline
A policy win that could accelerate drug approvals by 10 months.
STAT Coverage of Our Pilot Program at Caron Centers
Providing GLP-1s to inpatients with Dr. Steve Klein.
Updates on CASPR's Core Programs
Trials and projects that CASPR is running or making possible.
Podcast episode with Chris Hayes
Executive Director Nicholas Reville on addiction medicine, GLP-1s, and innovation policy.
An Innovation Agenda for Addiction
Federal policy proposals to accelerate breakthrough treatments for addiction, published with IFP and FAS.
VA study on GLP-1s and opioid use in veterans
Our first collaboration with the Department of Veterans Affairs.
Addiction medicine doctors who use GLP-1s
"I'm now offering GLP-1s to nearly all my substance use disorder patients."
